• / Free eNewsletters & Magazine
  • / My Account
Home>Search Results

Related Content

  1. Videos
  2. Articles
  1. Generic Biologics Face Uphill Battle

    Morningstar generic-pharmaceuticals analyst Brian Laegeler discusses the outlook for generic biologics in the U.S. given a strong branded-drug lobby and complex manufacturing processes.

  2. Will 'Knockout' Mice Make a Knockout Stock?

    After a strong runup from our recommendation, is it time to take money off the table in Lexicon Pharmaceuticals?

  3. Going Global to Ease Drug Trial Process

    Contract research organization Parexel is exploiting its global footprint to rapidly enroll patients in drug studies.

  4. Will a Medco/Express Scripts Merger Pass Regulatory Muster?

    Shareholders would be well-served by the pharmacy benefit managers' merger, but regulators are unlikely to sign off on it, says Morningstar's Matt Coffina.

  1. Watson Pharmaceuticals Inc. WPI Q1 2010 Earnings Call Transcript

    Good morning, my name is Therese and I will be your conference operator today. At this time, I d like to welcome everyone to the Watson Pharmaceuticals First Quarter 2010 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there ...

  2. Onyx Pharmaceuticals ONXX Q4 2012 Earnings Call Transcript

    Welcome to the Onyx Pharmaceuticals Conference Call. My name is Ellen, and I will be your operator for today's call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. Please note that this conference is being recorded.

  3. Alexion Pharmaceuticals ALXN Q4 2012 Earnings Call Transcript

    Good morning and welcome to the Alexion Pharmaceuticals Incorporated Fourth Quarter and Full Year 2012 Results Conference Call. Today's call is being recorded.

  4. Salix Pharmaceuticals SLXP Q4 2012 Earnings Call Transcript

    Good afternoon. My name is Katrina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Salix Pharmaceuticals Fourth Quarter 2012 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' ...

1
ShareEmail
Print
Text Size
Comment
blog comments powered by Disqus
Our Products
Tools
Resources
Services
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.